KFF Health News October 21, 2024
Susan Jaffe

When Pam McClure learned she’d save nearly $4,000 on her prescription drugs next year, she said, “it sounded too good to be true.” She and her husband are both retired and live on a “very strict” budget in central North Dakota.

By the end of this year, she will have spent almost $6,000 for her medications, including a drug to control her diabetes.

McClure, 70, is one of about 3.2 million people with Medicare prescription drug insurance whose out-of-pocket medication costs will be capped at $2,000 in 2025 because of the Biden administration’s 2022 Inflation Reduction Act, according to an Avalere/AARP study.

“It’s wonderful — oh my gosh. We would actually be able to live,” McClure said. “I might be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Patient / Consumer
What Are the Primary Medicaid Eligibility Pathways for Dual-Eligible Individuals?
Inflation Reduction Act saves 1.5M enrollees $1B: HHS
The days of fee-for-service are 'running out'
Medicare kicks off 2025 open enrollment
Most independent pharmacies may not carry negotiated Medicare Part D drugs

Share This Article